Pages that link to "Q37182375"
Jump to navigation
Jump to search
The following pages link to Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. (Q37182375):
Displaying 50 items.
- Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin (Q21296729) (← links)
- Current status of transarterial radioembolization (Q26744307) (← links)
- Arterial Therapies of Non-Colorectal Liver Metastases (Q26764990) (← links)
- Side effects of yttrium-90 radioembolization (Q26821887) (← links)
- Management of patients with hepatic metastases from neuroendocrine tumors (Q27008832) (← links)
- Neuroendocrine pancreatic tumors: guidelines for management and update (Q28256132) (← links)
- New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future. (Q30364864) (← links)
- Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel (Q33782024) (← links)
- Radioembolization of hepatic tumors (Q33820777) (← links)
- Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies (Q33840177) (← links)
- Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection (Q33851393) (← links)
- Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group (Q33894587) (← links)
- New Treatment Options for Patients with Advanced Neuroendocrine Tumors (Q34173336) (← links)
- ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary (Q34248487) (← links)
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (Q34301030) (← links)
- Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management (Q34389590) (← links)
- Update on pancreatic neuroendocrine tumors (Q34453043) (← links)
- Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference. (Q34702065) (← links)
- Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting (Q34743520) (← links)
- Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution (Q35018379) (← links)
- Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis (Q35046078) (← links)
- Research reporting standards for radioembolization of hepatic malignancies. (Q35111887) (← links)
- Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review (Q35371197) (← links)
- Radioembolization for primary and metastatic liver cancer. (Q35564038) (← links)
- Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost (Q35584891) (← links)
- Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. (Q35658025) (← links)
- Radioembolization in the treatment of neuroendocrine tumor metastases to the liver. (Q35659906) (← links)
- Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy (Q35675390) (← links)
- Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases (Q35721324) (← links)
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) (Q35760798) (← links)
- A multimodal approach to the management of neuroendocrine tumour liver metastases (Q35810562) (← links)
- Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes (Q35815482) (← links)
- Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma (Q35822196) (← links)
- Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. (Q35934322) (← links)
- PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy (Q36194191) (← links)
- Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data (Q36392298) (← links)
- Pancreatic Neuroendocrine Tumors: an Update (Q36400062) (← links)
- Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies (Q36512778) (← links)
- Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies (Q36656612) (← links)
- The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (Q36755905) (← links)
- A case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus (Q36877057) (← links)
- Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience (Q36936986) (← links)
- Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? (Q36955618) (← links)
- The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012 (Q36962070) (← links)
- Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases (Q36980633) (← links)
- Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances (Q37125550) (← links)
- Targeted radionuclide therapy (Q37148148) (← links)
- Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment (Q37354131) (← links)
- Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs). (Q37362261) (← links)
- Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome (Q37378933) (← links)